Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Weidemann

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
The Journal of International Medical Research|October 20, 2020
Non-invasive determination of pressure recovery by cardiac MRI and echocardiography in patients with severe aortic stenosis: short and long-term outcome predictionFlorian Sagmeister, Sebastian Herrmann, Tobias Gassenmaier, et al.
European Heart Journal|March 23, 2013
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry diseaseJohannes Krämer, Markus Niemann, Dan Liu, et al.
European Journal of Heart Failure|December 15, 2010
Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase AWolfram Machann, Frank Breunig, Frank Weidemann, et al.
Journal of Cardiac Failure|November 29, 2016
Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid RegurgitationKai Hu, Dan Liu, Stefan Störk, et al.
Kidney International. Supplement|April 16, 2003
Fabry disease: diagnosis and treatmentFrank Breunig, Frank Weidemann, Meinrad Beer, et al.
Plos One|January 30, 2014
Increased arterial diameters in the posterior cerebral circulation in men with Fabry diseaseNurcan Uçeyler, György A Homola, Hans Guerrero González, et al.
Clinical Endocrinology|July 22, 2014
Hypertension and hypertensive cardiomyopathy in patients with a relapse-free history of phaeochromocytomaDirk Weismann, Dan Liu, Till Bergen, et al.
Orphanet Journal of Rare Diseases|August 7, 2013
Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsFrank Weidemann, Maria D Sanchez-Niño, Juan Politei, et al.
Circulation. Cardiovascular Genetics|January 8, 2014
Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry diseaseMarkus Niemann, Arndt Rolfs, Stefan Störk, et al.
European Heart Journal. Cardiovascular Imaging|November 20, 2012
Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular diseaseKai Hu, Dan Liu, Sebastian Herrmann, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
The Journal of International Medical Research|October 20, 2020
Non-invasive determination of pressure recovery by cardiac MRI and echocardiography in patients with severe aortic stenosis: short and long-term outcome predictionFlorian Sagmeister, Sebastian Herrmann, Tobias Gassenmaier, et al.
European Heart Journal|March 23, 2013
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry diseaseJohannes Krämer, Markus Niemann, Dan Liu, et al.
European Journal of Heart Failure|December 15, 2010
Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase AWolfram Machann, Frank Breunig, Frank Weidemann, et al.
Journal of Cardiac Failure|November 29, 2016
Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid RegurgitationKai Hu, Dan Liu, Stefan Störk, et al.
Kidney International. Supplement|April 16, 2003
Fabry disease: diagnosis and treatmentFrank Breunig, Frank Weidemann, Meinrad Beer, et al.
Plos One|January 30, 2014
Increased arterial diameters in the posterior cerebral circulation in men with Fabry diseaseNurcan Uçeyler, György A Homola, Hans Guerrero González, et al.
Clinical Endocrinology|July 22, 2014
Hypertension and hypertensive cardiomyopathy in patients with a relapse-free history of phaeochromocytomaDirk Weismann, Dan Liu, Till Bergen, et al.
Orphanet Journal of Rare Diseases|August 7, 2013
Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsFrank Weidemann, Maria D Sanchez-Niño, Juan Politei, et al.
Circulation. Cardiovascular Genetics|January 8, 2014
Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry diseaseMarkus Niemann, Arndt Rolfs, Stefan Störk, et al.
European Heart Journal. Cardiovascular Imaging|November 20, 2012
Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular diseaseKai Hu, Dan Liu, Sebastian Herrmann, et al.
Pageof 16